相关实验视频
Updated: Jul 15, 2025
05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
4.6K
使用SAR405向自减轻了多克索鲁比诱导的心脏毒性
Xiaofan Sun1, Juan Du1, Heng Meng2
1Department of Hematology, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, Guangdong, China.
Cell biology and toxicology
|September 28, 2023
概括
德克索鲁比 (DOX) 化疗会导致心脏损伤 (心脏毒性),而德克斯拉松 (DEX) 虽然有帮助,但不足. 将DEX与新型自抑制剂SAR405结合起来,可以有效地预防这种心脏毒性.
科学领域:
- 在瘤学瘤学.
- 心脏病学 心脏病学
- 分子生物学分子生物学
背景情况:
- 像多克索鲁比辛 (DOX) 这样的人环素是重要的癌症药物,但会导致剂量限制性心脏毒性 (AIC).
- 德克斯拉佐 (DEX) 已被批准用于预防AIC,但在逆转已有的损害方面表现出有限的有效性.
- 自调节是AIC的潜在治疗途径,但新型抑制剂需要在相关模型中验证.
研究的目的:
- 评估新型自抑制在预防或逆转环素诱导心脏毒性 (AIC) 的有效性.
- 研究AIC中自启动的作用.
- 评估DEX和一种新型自抑制剂的联合治疗潜力.
主要方法:
- 利用慢性AIC小鼠模型来评估心脏毒性.
- 采用了Atg7的基因切除,这是一个关键的自调节器.
- 测试了新型自抑制剂SAR405,单独或与DEX结合使用.
- 在AIC期间,研究了心肌细胞细胞系 (AC16,H9c2) 中的自活化.
主要成果:
- 对Atg7的遗传删除提供了对DOX诱导的心脏毒性的保护.
- SAR405在减轻DOX诱导的细胞毒性方面表现出有效性.
- DEX和SAR405的组合在体内对心脏毒性提供了显著的保护.
- 观察到自在AIC过程中被启动.
结论:
- 早期的自抑制是对抗AIC的一个有希望的策略.
- 将DEX与自抑制剂SAR405结合起来,为预防AIC提供了一种强有力的治疗方法.
- 与常规心脏保护剂一起准自可能会提高化疗安全.
相关概念视频
01:18Autophagic Cell Death
3.4K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.4K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Autophagy
4.3K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.3K
01:26Heart Failure Drugs: Inotropic Agents
611
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
611
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
454
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
454